Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy

Medicine and Dentistry

• Diagnosis 100%
• Combination Therapy 100%
• Specimen 100%
• Ovarian Cancer 100%
• Analysis 66%
• Histology 66%
• Immunotherapy 66%
• Mitogen-Activated Protein Kinase 66%
• Hormone 66%
• Life 33%
• Gene 33%
• Immunohistochemistry 33%
• Biological Marker 33%
• Absence 33%
• Ligand 33%
• RNA 33%
• Targeted Therapy 33%
• Receptor Expression 33%
• Clinical Feature 33%
• Estrogen Receptor 33%
• Next Generation Sequencing 33%
• Exome 33%
• Fusion Gene 33%
• Progesterone Receptor 33%
• Molecular Pathology 33%
• Immunomodulating Agent 33%
• in Situ Hybridization 33%
• Hormone Cancer Therapy 33%